Skip to main content
. 2021 Jun 26;22(13):6879. doi: 10.3390/ijms22136879

Figure 2.

Figure 2

EGCG administration reduced WNT/FZ/β-catenin pathway activation: Western blot analysis of: WNT3a (A), FZ1 (B), FZ8 (C) expression. A p-value of less than 0.05 was considered significant. * p < 0.05 vs. sham, # p < 0.05 vs. vehicle.